BR9603826A - Processo para recuperar imunoglobulina de frações produzidas durante o fracionamento de plasma sanguíneo humano - Google Patents

Processo para recuperar imunoglobulina de frações produzidas durante o fracionamento de plasma sanguíneo humano

Info

Publication number
BR9603826A
BR9603826A BR9603826A BR9603826A BR9603826A BR 9603826 A BR9603826 A BR 9603826A BR 9603826 A BR9603826 A BR 9603826A BR 9603826 A BR9603826 A BR 9603826A BR 9603826 A BR9603826 A BR 9603826A
Authority
BR
Brazil
Prior art keywords
immunoglobulin
blood plasma
fractionation
recover
produced during
Prior art date
Application number
BR9603826A
Other languages
English (en)
Inventor
Jean-Jacques Morgenthaler
Hanspeter Amstutz
Peter G Lerch
Original Assignee
Rotkreuzstiftung Zentrallab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotkreuzstiftung Zentrallab filed Critical Rotkreuzstiftung Zentrallab
Publication of BR9603826A publication Critical patent/BR9603826A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
BR9603826A 1995-09-22 1996-09-20 Processo para recuperar imunoglobulina de frações produzidas durante o fracionamento de plasma sanguíneo humano BR9603826A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95810596A EP0764658B1 (de) 1995-09-22 1995-09-22 Verfahren zur Gewinnung von Immunglobulinen aus Fraktionen, die bei der Fraktionierung von menschlichem Blutplasma entstehen

Publications (1)

Publication Number Publication Date
BR9603826A true BR9603826A (pt) 1998-06-02

Family

ID=8221797

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9603826A BR9603826A (pt) 1995-09-22 1996-09-20 Processo para recuperar imunoglobulina de frações produzidas durante o fracionamento de plasma sanguíneo humano

Country Status (21)

Country Link
EP (1) EP0764658B1 (pt)
JP (1) JP2952572B2 (pt)
KR (1) KR100236762B1 (pt)
CN (1) CN1089609C (pt)
AT (1) ATE211486T1 (pt)
AU (1) AU715427B2 (pt)
BR (1) BR9603826A (pt)
CA (1) CA2185617A1 (pt)
CZ (1) CZ286885B6 (pt)
DE (1) DE59509979D1 (pt)
DK (1) DK0764658T3 (pt)
ES (1) ES2170788T3 (pt)
FI (1) FI963719A (pt)
HU (1) HUP9602570A3 (pt)
MX (1) MX9604256A (pt)
NO (1) NO963952L (pt)
NZ (1) NZ299394A (pt)
PL (1) PL316126A1 (pt)
PT (1) PT764658E (pt)
RO (1) RO117921B1 (pt)
RU (1) RU2157240C2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293119B1 (it) * 1997-06-12 1999-02-11 Mini Ricerca Scient Tecnolog Processo per la separazione di immunoglobuline specifiche da plasma standard e loro utilizzo per trattamenti terapeutici
US6159471A (en) 1997-10-23 2000-12-12 Yoshitomi Pharmaceutical Industries, Ltd. Room temperature storable immunoglobulin preparation for intravenous injection
JP4970260B2 (ja) 2004-08-20 2012-07-04 プロメティック バイオサイエンシズ，リミテッド 親和性クロマトグラフィーによるタンパク質の逐次的単離および精製スキーム
EP2233499A1 (en) 2009-03-26 2010-09-29 CSL Behring AG Antibody composition with altered Fab sialylation
WO2010148117A1 (en) * 2009-06-17 2010-12-23 Scantibodies Laboratory, Inc. Therapeutic and diagnostic affinity purified specific polyclonal antibodies
ITRM20090558A1 (it) * 2009-11-03 2011-05-04 Michele Pitaro Procedimento per la produzione di immunoglobuline estratte da plasma umano ad uso terapeutico neutralizzanti il virus di epstein barr e farmaco contenente dette immunoglobuline
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
JP5830096B2 (ja) * 2010-07-23 2015-12-09 バクスター、インターナショナル、インコーポレイテッド 血漿由来インターα阻害タンパク質（ＩａＩｐ）の製造方法
ES2531459B1 (es) * 2013-06-10 2015-12-28 Antonio VILA SANJURJO Método para la separación física de "traductomas" convolucionados
FR3018450B1 (fr) * 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
KR20150115639A (ko) * 2014-04-04 2015-10-14 전숙영 치료용 면역글로불린 제제 제조에 사용되는 산성 완충액, 이를 이용한 치료용 면역글로불린 제제 제조방법 및 이 제조방법으로 제조된 치료용 면역글로불린 제제
GB201413227D0 (en) * 2014-07-25 2014-09-10 Bioproducts Lab Ltd Process

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232004A (en) * 1977-09-21 1980-11-04 American National Red Cross Antibody-specific solid phase immunoadsorbent, preparation thereof, and antibody purification therewith
DE3516119A1 (de) * 1985-05-04 1986-11-06 Biotest Pharma GmbH, 6000 Frankfurt Polyvalentes hyperimmunglobulin-praeparat
IL90281A (en) * 1988-06-06 1994-10-07 Miles Inc Preparations containing MGI antibodies

Also Published As

Publication number Publication date
AU6572596A (en) 1997-04-10
DK0764658T3 (da) 2002-04-22
HUP9602570A3 (en) 1998-01-28
CN1153063A (zh) 1997-07-02
NO963952D0 (no) 1996-09-20
MX9604256A (es) 1998-04-30
ES2170788T3 (es) 2002-08-16
CA2185617A1 (en) 1997-03-23
FI963719A (fi) 1997-03-23
PT764658E (pt) 2002-06-28
JPH09124508A (ja) 1997-05-13
RU2157240C2 (ru) 2000-10-10
HU9602570D0 (en) 1996-11-28
NO963952L (no) 1997-03-24
NZ299394A (en) 1997-12-19
KR100236762B1 (ko) 2000-01-15
PL316126A1 (en) 1997-04-01
RO117921B1 (ro) 2002-09-30
CZ286885B6 (en) 2000-07-12
FI963719A0 (fi) 1996-09-19
AU715427B2 (en) 2000-02-03
EP0764658B1 (de) 2002-01-02
EP0764658A1 (de) 1997-03-26
CN1089609C (zh) 2002-08-28
DE59509979D1 (de) 2002-02-07
JP2952572B2 (ja) 1999-09-27
ATE211486T1 (de) 2002-01-15
CZ274896A3 (en) 1997-04-16
HUP9602570A2 (en) 1997-08-28
KR970015745A (ko) 1997-04-28

Similar Documents

Publication Publication Date Title
NO913186D0 (no) Fremgangsmaate for anvendelse og syntese av peptider.
KR950700779A (ko) 단백질의 정제방법(Protein purification)
BR9603826A (pt) Processo para recuperar imunoglobulina de frações produzidas durante o fracionamento de plasma sanguíneo humano
WO2003059935A3 (en) Methods for purifying protein
CA2183888A1 (en) Antibody purification
DK0821695T3 (da) Oprensning af antistof ved hydrofob interaktionschromatografi ved lav pH-værdi
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
NO20090583L (no) Terapi for alfa-galaktosidase A-mangel
DK0408029T3 (da) Fremgangsmåde til fraktionering af plasmaprotein
DE59209129D1 (de) Verwendung von Antikörper enthaltenden Präparationen zur Immunsuppression
AU640699B2 (en) Carrier for binding antiphospholipid antibody, immunoassay using the same, and kit therefor
DE3887750D1 (de) Selektive entfernung von immunkomplexen.
DK0763100T3 (da) Fremgangsmåde til rensning af Clostridium difficile-texin og fremstilling af monospecifkke antistoffer
GR3030212T3 (en) Platelet activating factor antagonists.
ES2041690T3 (es) Metodo para la purificacion de anticuerpos.
ATE155481T1 (de) Verfahren zur reinigung von streptolysin 0, intaktes streptolysin 0 erhältlich nach diesem verfahren und seine verwendung
DK0401657T3 (da) Fremgangsmåde til C-terminal modificering af proteiner
GR970300022T1 (en) Peptide capable of being recognised by antibodies recognising the C33 antigen of hepatitis C virus
ATE184315T1 (de) Neuartiges endothelzell-molekül, das die bindung von lymphozyten im menschen vermittelt
AU3432389A (en) Human monoclonal antibodies against rabies virus
GB2021593A (en) A Purified Cancer Associated Protein
RU95120418A (ru) Способ получения альфа-фетопротеина
ATE193021T1 (de) Lipoprotein (a)-peptide und deren verwendung
NO892022L (no) Fremgangsmaate ved adsorptiv utskillelse av para-alkylaromatiske hydrocarboner ved bruk av en fluoraromatisk desorbent.

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
PC Transfer

Free format text: ZLB BIOPLASMA AG (CH)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]